Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Periocline is a topical antibiotic formulation containing minocycline hydrochloride, a semi-synthetic tetracycline-class antibiotic. It is primarily used as an adjunctive treatment in periodontal therapy, specifically for adult periodontitis. Periocline is applied directly into the periodontal pocket as an ointment or gel to reduce bacterial load and inflammation associated with gum disease. The mechanism of action involves inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the growth and proliferation of susceptible bacteria within the periodontal pocket[3][4]. Minocycline exhibits broad-spectrum antibacterial activity and is effective against many gram-positive and gram-negative organisms commonly implicated in periodontitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on periocline.